The Centers for Disease Control and Prevention’s (CDC) vaccine advisory committee has voted to lift the pause on the Johnson & Johnson (J&J) COVID-19 vaccine with no restrictions, saying the vaccine’s benefits outweigh the risks, at an emergency meeting on Friday. Members of the Advisory Committee on Immunization Practices (ACIP) said that they recommend resuming the use of the J&J vaccines in persons age 18 and older after a robust discussion and examination of the available data on the severe blood clotting syndrome with low platelet levels associated with taking the vaccine. Members voted on the original motion that was passed by the committee back in February: “The Janssen COVID-19 vaccine is recommended for persons 18 years of age and older in the U.S. population under the FDA’s [Food and Drug Administration] Emergency Use Authorization [EUA].” Ten of the members voted in favor of the recommendation, four opposed, and one …